As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
At Codorus Valley Bancorp, a filing with the SEC revealed that on Wednesday, Director John W.
Giambalvo bought 4,672 shares of CVLY, for a cost of $21.35 each, for a total investment of $99,747.
Giambalvo was up about 7.0% on the purchase at the high point of today's trading session, with CVLY trading as high as $22.84 at last check today.
Codorus Valley Bancorp is trading up about 2.2% on the day Monday.
Before this latest buy, Giambalvo made one other purchase in the past year, buying $32,333 shares for a cost of $19.73 each.
And at Harpoon Therapeutics, there was insider buying on Wednesday, by Chief Financial Officer Georgia Erbez who purchased 10,300 shares for a cost of $8.10 each, for a trade totaling $83,430.
This buy marks the first one filed by Erbez in the past year.
Harpoon Therapeutics is trading up about 0.5% on the day Monday.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider..
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider..
